Status and phase
Conditions
Treatments
About
evaluation of the efficacy and safety of D-dimer adjusted heparin versus therapeutic dose heparin in patients with COVID-19 Pneumonia.
Full description
The following will be done for enrolled patients:
Data collection: name, age, sex, special habits of medical importance (i.e. smoking, drug abuse), comorbid conditions.
Clinical examination Vital data Local chest examination
Measurement of oxygen saturation using pulse oximeter
Laboratory investigations:
Complete blood count with differential count Liver and kidney functions D-dimer level Coagulation profile
Radiology work up ( Chest X-ray-High resolution computed tomography of the chest- computed tomography of the chest with pulmonary angiography as needed)
Sepsis-induced coagulopathy score (SIC score)
Sequential organ failure score (SOFA score)
Patients will receive treatment according to the hospital guidelines for different disease stratification severity
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Central trial contact
Ashraf Madkour
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal